» Articles » PMID: 30114663

Fasciculation Intensity and Disease Progression in Amyotrophic Lateral Sclerosis

Overview
Publisher Elsevier
Specialties Neurology
Psychiatry
Date 2018 Aug 17
PMID 30114663
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the association between the frequency and intensity of fasciculations with clinical measures of disease progression in amyotrophic lateral sclerosis (ALS).

Methods: Twenty-four consecutive patients with ALS underwent clinical review and neuromuscular ultrasound assessment to detect intensity of fasciculations. Results were correlated with clinical markers of disease severity, as measured by the ALS Functional Rating Scale-revised (ALSFRS-R) and rate of disease progression (ΔFS), in addition to assessment of cortical motor function.

Results: Disease duration negatively correlated (R = -0.530, p < 0.01) with fasciculation intensity, while the ΔFS positively correlated with the fasciculation number (R = 0.626, p < 0.01). In terms of potential central contributions to ectopic impulse generation, patients were classified into cohorts based on their fasciculation intensity and short interval intracortical inhibition (SICI). ΔFS was significantly higher in patients with established hyperexcitability (low SICI) with high fasciculation intensity compared to those patients with minimal SICI change.

Conclusions: Fasciculation intensity appears linked to disease progression and separately to markers of cortical dysfunction, specifically the advent of cortical hyperexcitability.

Significance: Assessment of the intensity of patient fasciculations is a noninvasive approach that may provide further insight disease pathophysiology in ALS.

Citing Articles

Fasciculation potentials are related to the prognosis of amyotrophic lateral sclerosis.

Ohnari K, Mafune K, Adachi H PLoS One. 2024; 19(11):e0313307.

PMID: 39514515 PMC: 11548741. DOI: 10.1371/journal.pone.0313307.


Progressive spastic tetraplegia and axial hypotonia (STAHP) due to SOD1 deficiency: is it really a new entity?.

Souza P, Pinto W, Farias I, Badia B, Pinto I, Costa G Orphanet J Rare Dis. 2021; 16(1):360.

PMID: 34380534 PMC: 8359534. DOI: 10.1186/s13023-021-01993-0.


Fasciculation score: a sensitive biomarker in amyotrophic lateral sclerosis.

Ma J, Wen Q, Pang X, Huang S, Zhang J, Wang J Neurol Sci. 2021; 42(11):4657-4666.

PMID: 33704599 DOI: 10.1007/s10072-021-05166-6.


Fasciculation frequency is a questionable biomarker for motor unit loss in amyotrophic lateral sclerosis.

Finsterer J, Scorza F Brain Commun. 2021; 2(2):fcaa188.

PMID: 33428690 PMC: 7784040. DOI: 10.1093/braincomms/fcaa188.


Muscle ultrasound: Present state and future opportunities.

Wijntjes J, van Alfen N Muscle Nerve. 2020; 63(4):455-466.

PMID: 33051891 PMC: 8048972. DOI: 10.1002/mus.27081.